Highest-materiality recent filing
Leggett & Platt completes merger with Somnigroup; shares converted at 0.1455 ratio
Merger closed Aug 26, 2026; LEG shareholders receive 0.1455 Somnigroup shares per LEG share.
Leggett & Platt merger clears all regulatory approvals; closing expected Aug 26, 2026
All requisite regulatory approvals received as of Aug 25, 2026; closing anticipated as early as Aug 26, 2026.
Leggett & Platt shareholders approve merger with Somnigroup (SGI)
Special meeting Aug 20, 2026: 109,747,006 shares (80.35%) voted, quorum met.
Leggett & Platt Reports Q2 2026 Results; Sales Down 6% to $1.0B, Adjusted EPS Up to $0.39
Q2 sales $1.0B, down 6% vs Q2 2025; organic sales down 1%; volume down 4%.
Leggett & Platt HSR waiting period expires; merger on track for year-end 2026 close
HSR waiting period expired on June 3, 2026, clearing one antitrust condition.
Leggett & Platt Q1 sales $918M, EPS $0.14; withdraws FY2026 guidance amid Somnigroup deal
Sales $918M, down 10% YoY; organic sales down 5%; volume down 9%.
Somnigroup to acquire Leggett & Platt in ~$2.5B all-stock deal; exchange ratio 0.1455
Leggett & Platt shareholders receive 0.1455 Somnigroup shares per share, owning ~9% of combined company.
Leggett & Platt 2025 sales $4.05B (-7%), EPS $1.69; guides 2026 sales $3.8-4.0B
4Q sales $939M (-11% YoY); adjusted EPS $0.22 (up $0.01 YoY).
Leggett & Platt 3Q sales down 6% to $1.0B; adj EPS $0.29 vs $0.32; reaffirms guidance midpoint
3Q sales $1.0B (-6% YoY); adj EPS $0.29 (down $0.03); EBIT $171M including $87M Aerospace gain.
Leggett & Platt closes sale of Aerospace Products Group for ~$285M; revises FY2025 guidance
Sale closed Aug 29, 2025; cash proceeds ~$285.8M at closing, expected after-tax ~$250M.
Leggett & Platt Q2 adj. EPS $.30, up $.01 YoY; sales down 6% to $1.1B; FY guidance maintained
Q2 adjusted EPS $.30, up $.01 YoY; GAAP EPS $.38 vs. loss of $4.39 in 2Q24.
Leggett & Platt Q1 adjusted EPS $0.24 beats; sales down 7%; FY25 guidance unchanged
Q1 sales $1.0B (-7% YoY); EPS $0.22, adjusted EPS $0.24 (+$0.01 vs adjusted 1Q24).
Leggett & Platt sells Aerospace Products Group to Tinicum for $285M cash
Cash purchase price $285M; after-tax proceeds expected ~$240M.
Q4 sales $1.1B (−5% YoY); EPS $0.10, adj. EPS $0.21 (down $0.05 from Q4 2023 adj. EPS $0.26).
Leggett & Platt Q3 sales down 6% to $1.1B; lowers FY2024 adjusted EPS guidance to $1.00-$1.10
Q3 sales $1.1B (-6% YoY); adjusted EPS $0.32 (down from $0.36 in Q3 2023).
Q2 sales $1.1B (-8% YoY); GAAP EPS loss $4.39 includes $675M non-cash goodwill impairment.
Leggett & Platt appoints Karl Glassman as President and CEO; Mitch Dolloff resigns
J. Mitchell Dolloff resigned immediately as President, CEO and Board member; not due to any disagreement.
Leggett & Platt 1Q sales $1.1B (-10% YoY); dividend slashed to $0.05 from $0.46
1Q EPS $0.23, down $0.16 YoY; adjusted EPS also $0.23.
Leggett & Platt loosens leverage covenant to 4.0x through mid-2025; evaluates dividend
Leverage ratio covenant increased from 3.5x to 4.0x for quarters March 31, 2024 through June 30, 2025; reverts to 3.5x Sept 30, 2025.
Leggett & Platt reports Q4 loss of $2.18 EPS, $444M impairment; guides 2024 adj EPS $1.05-1.35
Q4 sales $1.1B (-7% YoY), GAAP EPS loss of $2.18 vs $0.39 prior; adjusted EPS $0.26, down $0.13.
Leggett & Platt announces restructuring, $450M impairment, withdraws long-term targets
Restructuring plan consolidates 15-20 of 50 Bedding facilities; cuts 900-1,100 jobs; targets $40-50M annualized EBIT by late 2025.
Leggett & Platt Q3 sales fall 9%, EPS down; lowers 2023 guidance on weak residential demand
Q3 sales $1.18B (-9% YoY); EPS $0.39 vs $0.52; adjusted EPS $0.36 vs $0.52.
Leggett & Platt Q2 sales $1.22B (-8% YoY); lowers FY2023 guidance
EPS $0.40, down $0.30 YoY; adjusted EPS $0.38, down $0.32.
Leggett & Platt appoints Benjamin M. Burns as CFO, replacing Jeffrey L. Tate
Benjamin M. Burns appointed EVP and CFO effective June 21, 2023, replacing Jeffrey L. Tate.
Leggett & Platt Q1 sales $1.21B (-8% YoY), EPS $0.39; guidance unchanged
Q1 EPS $0.39 (down $0.27 vs Q1 2022); EBIT $89M (down $48M); EBIT margin 7.4%.
Karl G. Glassman to retire as executive officer effective May 4, 2023; expected to serve as Chairman if re-elected.
Leggett & Platt reports Q4 EPS $0.39, down 49% YoY; guides 2023 EPS $1.50-$1.90
Q4 EPS $0.39, down $0.38 YoY; sales $1.2B, down 10% (12% volume decline).
Leggett & Platt Q3 EPS $0.52, down $0.19 YoY; sales $1.29B, down 2%
Q3 sales $1.29B (down 2% YoY); EBIT $113M (down $31M); EPS $0.52 (down $0.19).
Leggett & Platt lowers FY2022 guidance; cuts EPS view to $2.30-2.45, sales to $5.1-5.2B
Sales guidance lowered to $5.1-5.2B from $5.2-5.4B; EPS down to $2.30-2.45 from $2.65-2.80.
Leggett & Platt Q2 sales record $1.33B but lowers full-year guidance; EPS $0.70
Q2 sales record $1.33B (+5% YoY); EPS $0.70 (down $0.12 YoY).
Leggett & Platt reports record Q1 sales $1.32B, EPS $0.66; raises dividend to $0.42
Record Q1 sales $1.32B (+15% YoY); record EPS $0.66, up $0.02 from Q1 2021.
Leggett & Platt reports record Q4 sales $1.33B, FY sales $5.07B, 2022 guidance $5.3-5.6B
Q4 sales record $1.333B (+13% YoY); EPS $0.77 (-$0.02 YoY).
At the closing of the Merger, Karl G. Glassman, Angela Barbee, Robert E. Brunner, Mary Campbell, Joseph W. McClanathan, Srikanth Padmanabhan, Jai Shah and Phoebe A. Wood, members of the board of directors of the Company, ceased to be directors of the Company, as the surviving entity of the Merger, pursuant to the terms of the Merger Agreement.
At the closing of the Merger, Karl G. Glassman, Angela Barbee, Robert E. Brunner, Mary Campbell, Joseph W. McClanathan, Srikanth Padmanabhan, Jai Shah and Phoebe A. Wood, members of the board of directors of the Company, ceased to be directors of the Company, as the surviving entity of the Merger, pursuant to the terms of the Merger Agreement.
At the closing of the Merger, Karl G. Glassman, Angela Barbee, Robert E. Brunner, Mary Campbell, Joseph W. McClanathan, Srikanth Padmanabhan, Jai Shah and Phoebe A. Wood, members of the board of directors of the Company, ceased to be directors of the Company, as the surviving entity of the Merger, pursuant to the terms of the Merger Agreement.
At the closing of the Merger, Karl G. Glassman, Angela Barbee, Robert E. Brunner, Mary Campbell, Joseph W. McClanathan, Srikanth Padmanabhan, Jai Shah and Phoebe A. Wood, members of the board of directors of the Company, ceased to be directors of the Company, as the surviving entity of the Merger, pursuant to the terms of the Merger Agreement.
At the closing of the Merger, Karl G. Glassman, Angela Barbee, Robert E. Brunner, Mary Campbell, Joseph W. McClanathan, Srikanth Padmanabhan, Jai Shah and Phoebe A. Wood, members of the board of directors of the Company, ceased to be directors of the Company, as the surviving entity of the Merger, pursuant to the terms of the Merger Agreement.
At the closing of the Merger, Karl G. Glassman, Angela Barbee, Robert E. Brunner, Mary Campbell, Joseph W. McClanathan, Srikanth Padmanabhan, Jai Shah and Phoebe A. Wood, members of the board of directors of the Company, ceased to be directors of the Company, as the surviving entity of the Merger, pursuant to the terms of the Merger Agreement.
At the closing of the Merger, Karl G. Glassman, Angela Barbee, Robert E. Brunner, Mary Campbell, Joseph W. McClanathan, Srikanth Padmanabhan, Jai Shah and Phoebe A. Wood, members of the board of directors of the Company, ceased to be directors of the Company, as the surviving entity of the Merger, pursuant to the terms of the Merger Agreement.
At the closing of the Merger, Karl G. Glassman, Angela Barbee, Robert E. Brunner, Mary Campbell, Joseph W. McClanathan, Srikanth Padmanabhan, Jai Shah and Phoebe A. Wood, members of the board of directors of the Company, ceased to be directors of the Company, as the surviving entity of the Merger, pursuant to the terms of the Merger Agreement.
On February 25, 2025, Mark A. Blinn and Manuel A. Fernandez each notified the Company of their respective decisions to retire as a director of the Company effective immediately prior to the beginning of the 2025 annual shareholder meeting, which currently is expected to be held on May 7, 2025.
On February 25, 2025, Mark A. Blinn and Manuel A. Fernandez each notified the Company of their respective decisions to retire as a director of the Company effective immediately prior to the beginning of the 2025 annual shareholder meeting, which currently is expected to be held on May 7, 2025.
On February 13, 2025, Karl G. Glassman, the Company’s President and Chief Executive Officer, ceased serving as the acting, temporary segment manager of the Company’s Specialized Products segment.
On this same date, the Company appointed R. Samuel Smith, Jr. to serve as President of the Specialized Products segment.
Max materiality 0.90 · Median 0.70 · Most common event earnings